InvestorsHub Logo
Followers 88
Posts 1168
Boards Moderated 0
Alias Born 09/10/2017

Re: Horseb4CarT post# 422907

Wednesday, 12/01/2021 2:21:30 AM

Wednesday, December 01, 2021 2:21:30 AM

Post# of 701587
Yes, I think that 40-45 patient number is the production capacity using the current manual process. The last paragraph of that PR discussed the Flaskworks system:

As previously reported, the Company has also been moving forward on optimization of the Flaskworks system for manufacturing of dendritic cell vaccines. The buildout of the Sawston facility is purposefully being done in phases, both for efficiency in the timing of capital costs and to allow flexibility in operations and usage. It is anticipated that implementation of the Flaskworks system will enable the buildout of some or all of the rest of the 88,345 square foot facility, beyond the initial manufacturing suites, to be simplified and streamlined at reduced cost.

https://nwbio.com/northwest-biotherapeutics-announces-development-completed-for-initial-production-capacity-of-sawston-uk-facility/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News